Search results
Verona's ensifentrine garners favorable reviews ahead of anticipated US launch for COPD
BioPharma-Reporter· 4 days agoThe first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor aims to reduce exacerbations in COPD...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 7 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
Medical Breakthroughs: New procedure treating COPD
KRGV Rio Grande Valley· 1 day agoChronic obstructive pulmonary disease, also known as COPD, is a condition that limits airflow in and out of the lungs, making it difficult to breathe.
Mr José Luis Castro appointed as WHO Director-General Special Envoy for Chronic Respiratory Diseases
World Health Organization· 16 hours agoThe World Health Organization (WHO) is pleased to announce the appointment of Mr José Luis Castro as...
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type...
Morningstar· 7 days agoFood and Drug Administration (FDA) has extended by three months the target action date of its priority review of the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab ...
Bronchial Rheoplasty Unplugs Mucus in Chronic Bronchitis
Medscape· 3 days ago"Mucus plugging, opacities within the lumen of an airway seen on CT scan, is a relatively new...
Asthma inhalers are now more affordable in Illinois, and that's a breath of fresh air for many
Chicago Sun-Times· 11 hours agoThe Respiratory Health Association applauds the Illinois General Assembly for passing an amendment...
Frequent Cannabis Use Increases Risk for Lung Diseases
Medscape· 7 days agoResearch presented at the 2024 SGIM meeting suggested daily cannabis use may heighten asthma and ...
California tells people to avoid gas stations
Newsweek· 11 hours agoCalifornia officials are warning people in Imperial County to delay visiting gas stations and using chemicals until ozone levels improve. On Wednesday...
Boehringer Ingelheim's COPD and asthma inhalers are now available for $35 a month for eligible...
KOLR - KSFX Ozarks· 6 days agoBoehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company's inhalers is now available. With this program, patients who have had difficulty ...